Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

$CURI stock is up 25% today. Here's what we see in our data.

None

$CURI stock has now risen 25% today, according to our price data from Polygon. There has been approximately $19,697,741 of trading volume.

It has been the 67th most-searched ticker on Quiver Quantitative over the last day, out of 9,941 total tickers searched.

Here is what we see in our data on $CURI (you can track the company live on Quiver's $CURI stock page):

$CURI Insider Trading Activity

CURI Insider Trades

$CURI insiders have traded $CURI stock on the open market 26 times in the past 6 months. Of those trades, 0 have been purchases and 26 have been sales.

Here’s a breakdown of recent trading of $CURI stock by insiders over the last 6 months:

  • JOHN S HENDRICKS has made 0 purchases and 8 sales selling 8,650,000 shares for an estimated $31,262,521.
  • CLINTON LARRY STINCHCOMB (President and CEO) has made 0 purchases and 2 sales selling 332,486 shares for an estimated $1,556,733.
  • JONATHAN HUBERMAN has made 0 purchases and 9 sales selling 200,000 shares for an estimated $916,926.
  • PHILLIP BRADY HAYDEN (Chief Financial Officer) has made 0 purchases and 3 sales selling 69,235 shares for an estimated $298,384.
  • REBECCA R REED (Gen Counsel) has made 0 purchases and 2 sales selling 4,832 shares for an estimated $19,620.
  • ANDREW HENDRICKS has made 0 purchases and 2 sales selling 4,000 shares for an estimated $19,208.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CURI Hedge Fund Activity

We have seen 71 institutional investors add shares of $CURI stock to their portfolio, and 35 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$CURI Analyst Ratings

Wall Street analysts have issued reports on $CURI in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Barrington Research issued a "Outperform" rating on 11/13/2025
  • Needham issued a "Buy" rating on 09/25/2025

To track analyst ratings and price targets for $CURI, check out Quiver Quantitative's $CURI forecast page.

$CURI Price Targets

Multiple analysts have issued price targets for $CURI recently. We have seen 3 analysts offer price targets for $CURI in the last 6 months, with a median target of $6.0.

Here are some recent targets:

  • Patrick Sholl from Barrington Research set a target price of $6.0 on 11/13/2025
  • Laura Martin from Needham set a target price of $6.0 on 09/25/2025

You can track data on $CURI on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles